STAAR Surgical Company
STAA
$18.84
$0.452.45%
NASDAQ
| 01/02/2026 | 09/26/2025 | 06/27/2025 | 03/28/2025 | 12/27/2024 | |
|---|---|---|---|---|---|
| Net Income | 46.51% | -10.98% | -327.84% | -1,523.57% | -541.31% |
| Total Depreciation and Amortization | -15.49% | 13.83% | 29.76% | 88.92% | 95.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 40.13% | 98.68% | -70.71% | 140.44% | 209.49% |
| Change in Net Operating Assets | -96.24% | -59.68% | 49.00% | 74.80% | 20.31% |
| Cash from Operations | -709.66% | -30.11% | -161.68% | -126.45% | -97.99% |
| Capital Expenditure | 70.71% | 85.83% | 71.26% | 71.78% | -85.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -28.82% | 121.25% | 286.47% | 72.14% | -154.02% |
| Cash from Investing | 0.41% | 114.99% | 221.54% | 118.39% | -187.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | 100.00% | -5.00% | -2.50% |
| Issuance of Common Stock | 185.00% | 78.94% | -96.77% | -92.92% | -90.20% |
| Repurchase of Common Stock | -50.46% | -- | -2,625.75% | -4.39% | -10,800.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 54.55% | -39.13% | -2,885.28% | -123.37% | -129.97% |
| Foreign Exchange rate Adjustments | 142.45% | -91.22% | 307.88% | 130.52% | -201.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.93% | 131.36% | 80.85% | -29.35% | -135.69% |